Our Pipeline

Our pipeline of immune modulators and precision therapies for multiple solid tumors address patient populations in need of better cancer therapies.

Five Prime Programs

Bemarituzumab

FGFR2b antibody
1L gastric/GEJ cancer

FPT155

CD80-Fc Fusion
Multiple tumor settings

FPA150

B7-H4 antibody
Breast, ovarian and endometrial cancers
Multiple tumor settings

Partnered Programs

BMS-986258

TIM-3 antibody
Multiple tumor settings
Multiple tumor settings

Antibody-drug Conjugates

Multiple tumor settings